基因编辑的良法善治：在谦抑与开放之间

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (571 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Gene editing has caused great controversy on global scale, and it is of urgent need to strengthen legal regulation in this regard. Gene editing is of great significance in helping precision medicine and improving human health, but it has huge potential risks. In awe of life, and in view of the current technical immaturity, the law regulating genetic editing must be in agreement with the modesty and restraint principle and defend the bottom line of human dignity. At the same time, the law should be moderately open, leaving space for scientific progress and social development. At present, the law should only offer limited permit to the researches and applications of genetic editing whose safety has been verified, including gene editing and somatic gene editing in basic research and preclinical research. The clinical trials and applications of germline gene editing and gene editing for enhancement should be banned at present, but the ban may be lifted in the future when their safety is verified and social consensus is reached and effective supervisions are in place.

Key words： gene editing risk proper regulation modesty principle openness limited permit

Received: 06 May 2018

D920.0

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	TIAN Ye
	LIU Xia

Cite this article:

TIAN Ye,LIU Xia. Proper Regulation of Gene Editing: Being Modest and Open[J]. , 2018, 35(4): 106-115.

URL:

https://xb.szu.edu.cn/EN/ OR https://xb.szu.edu.cn/EN/Y2018/V35/I4/106

[1] 王康. 人类基因编辑多维风险的法律控制[J].求索,2017,(11):98-107.
[2] Michael A. Grodin,Erin L.Miller and Johnathan I. Kelly. The Nazi Physicians as Leaders in Eugenics and Euthanasia:Lessons for Today[J].American Journal of Public Health,2018,108(1):53-57.
[3] Tatlow D K. A Scientific Ethical Divide Between China and West[N]. The New York Times,2015-06-29(Health & Medicine).
[4] Anon. 365 Days:Nature’s 10:Ten People Who Mattered This Year[EB/OL].(2015-12-17)[2016-05-18]. http://www.nature.com/news/365-days-nature-s-10-1.19018.
[5] Edward Lanphier & Fyodor Urnov. Don’t Edit the Human Germ Line[J].Nature,2015,519(7544):410-411.
[6] Tina Hesman Saey.Genes & cells:Editing Human Germline Cells Debated: New Techniques for Modifying Genes Raise Ethical Questions[J].Science News,2015, 187(11):16-17.
[7] M Nthling Slabbert.MS Pepper. A global comparative Overview of the Legal Regulation of Stem Cell Research and Therapy:Lessons for South Africa[J]. South African Journal of Bioethics and Law,2015,8(2):12-22.
[8] Harris. John.Germline Modification and the Burden of Human Existence[J].Cambridge Quarterly of Healthcare Ethics,2016,25(1):6-18.
[9] 张新庆. 基因治疗之伦理审视[M]. 北京:中国社会科学出版社,2014.163.
[10] Brooke Elizabeth Hrouda.Playing God:An Examination of the Legality of CRISPR Germline Editing Technology under the Current International Regulatory Scheme and the Universal Declaration on the Human Genome and Human Rights[J].Georgia Journal of International and Comparative Law,2016,45(1):221-242.
[11] Liao S.Matthew. Do Mitochondrial Replacement Techniques Affect Qualitative or Numerical Identity?[J]. Bioethics,2017,31(1):21-26.
[12] R. Isasi,E. Kleiderman, etc. Editing Policy to Fit the Genome[J].Science,2016,351(6271):337.
[13] James Lawfor Davies.The Regulation of Gene Editing in the United Kingdom[J].The SciTech Lawyer,2016,13(1):14-17.
[14] Callaway Ewen.Gene-editing Research in Human Embryos Gains Momentum: Experiments are Now Approved in Sweden,China and the United Kingdom[J]. Nature,2016,532(7599):289-290.
[15] Russell A. Spivak,I.Glenn Cohen and Eliy Adashi. Germline Gene Editing And Congressional Reaction In Context:Learning From Almost 50 Years Of Congressional Reactions To Biomedical Breakthroughs[J].Journal of Law & Health,2017,30(1):20-54.
[16] T.Ishii.Potential Impact of Human Mitochondrial Replacement on Global Policy Regarding Germline Gene Modification[J].Reproductive Biomedicine Online, 2014,29(2):150-155.
[17] Liam W.Harri.Recognizing and Legitimizing the Tran-snational Scientific Governance of Human Gene Editin[J].McGill Journal of Law and Health,2017,11(2):87-140.
[18] 沈秀琴. 人体基因科技医学运用立法规制研究[M].济南:山东大学出版社,2015.30.
[19] Gilbert Meilaender.Is Caution Enough? The Promise & Peril of Gene Editing[J]. Commonweal,2017,144(7):12-15.
[20] 邱仁宗. 基因编辑技术的研究和应用:伦理学视角[J].医学与哲学,2016,(7):1-7.
[21] Sarah Chan,etal.Genome Editing Technologies and Human Germline Genetic Modification:The Hinxton Group Consensus Statement[J].American Journal of Bioethics,2015,15(12):42-47.